Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01016938 · ClinicalTrials.gov registry record

Dynamic Magnetic Resonance Imaging (MRI) for Lung Tumor Motion and Lung Function (GCC 0943)

A clinical trial, sponsored by University of Maryland, Baltimore.

Completed
Registry status
16
Enrollment target

NCT01016938 is a clinical trial that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 16 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01016938 has completed, sponsored by University of Maryland, Baltimore.

COMPLETED
Registry status
16 participants
Enrollment target

Study Summary

Radiation treatment for each patient with cancer is designed based on CT scans. We know that tumors in the chest and abdomen move when you breathe. Because of this, there can be differences between planned treatment and the treatment actually delivered to the body. Usually with radiation a safety margin is added to ensure that radiation hits the entire tumor. This can damage healthy parts of the body because the exact location of the tumor is unknown. Magnetic resonance imaging (MRI) is a painless and safe diagnostic procedure that uses a powerful magnet and radio waves to produce detailed images of the body's organs and structures, without the use of X-rays or other radiation. The research doctors are studying to see if the position of a tumor can be tracked using MRI scans and tracking sensors placed on the skin. MRI scans and the tracking system used to calculate the location and position of the tumor are both FDA approved technologies. The research doctors will also use the MRI scans to evaluate any changes in your lung function during and following your radiation treatments. In this study the participant will undergo a series of MRI scans with and without contrast dye. This study is being funded through grants from the National Institutes of Health (NIH).

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2009-11
Est. Completion 2015-10

Sponsor

University of Maryland, Baltimore

560 total trials

What the Registry Record Tells You About NCT01016938

The ClinicalTrials.gov registry entry for NCT01016938 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01016938 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01016938 about?

NCT01016938 is a clinical study titled "Dynamic Magnetic Resonance Imaging (MRI) for Lung Tumor Motion and Lung Function (GCC 0943)". Radiation treatment for each patient with cancer is designed based on CT scans. We know that tumors in the chest and abdomen move when you breathe. Because of this, there can be differences between planned treatment and the treatment actually delivered to the body. Usually with radiation a safety ma...

What is the current status of trial NCT01016938?

This trial is currently completed. The enrollment target is 16 participants. The study started on 2009-11. Estimated completion is 2015-10.

Who is sponsoring clinical trial NCT01016938?

This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.